Elizabeth Armstrong-Mensah, Pamela Hernandez, Madina Huka, Angie Suarez, Adeola Akosile, Ann Joseph, Kim Ramsey-White
{"title":"HIV Stigma among Women and Adolescent Girls in South Africa: Removing Barriers to Facilitate Prevention","authors":"Elizabeth Armstrong-Mensah, Pamela Hernandez, Madina Huka, Angie Suarez, Adeola Akosile, Ann Joseph, Kim Ramsey-White","doi":"10.18689/mja-1000112","DOIUrl":"https://doi.org/10.18689/mja-1000112","url":null,"abstract":"","PeriodicalId":337186,"journal":{"name":"Madridge Journal of AIDS","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132809144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lars E Eriksson Lise-Lott Rydström, A. Berlin, Lise-Lott Rydström
{"title":"“The Medication always Reminds Me”. Living with Perinatal acquired HIV-Children and Parentsʼ View Points","authors":"Lars E Eriksson Lise-Lott Rydström, A. Berlin, Lise-Lott Rydström","doi":"10.18689/mja-1000111","DOIUrl":"https://doi.org/10.18689/mja-1000111","url":null,"abstract":"Lise-Lott Rydström1*, Lars E Eriksson2-4 and Anita Berlin1 1Division of Nursing, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockhom, Sweden 2Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, SE-171 77 Stockholm, Sweden 3Department of Infectious Diseases, Karolinska University Hospital, SE-141 86 Huddinge, Sweden 4School of Health Sciences, City, University of London, London EC1V 0HB, United Kingdom","PeriodicalId":337186,"journal":{"name":"Madridge Journal of AIDS","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114829686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Single-Tablet Regimen containing Elvitegravir in an HIV-2 Infected Patient","authors":"R. Abreu, Frederico Duarte, I. Neves","doi":"10.18689/mja-1000110","DOIUrl":"https://doi.org/10.18689/mja-1000110","url":null,"abstract":"HIV-2 was first identified in 1986 in West African patients at Institute Pasteur [1]. Initially typed as non-HIV-1, it shows very similar biological and morphological properties to HIV-1 but presents itself with different antigens and envelope-glycoproteins, making it more closely related to the simian virus. HIV-2 has always been a challenge to treat due to a limited set of drugs and to follow-up, as a result of a lack of correlation between viral load, immunological status and clinical evolution. The largest HIV-2 cohorts outside Africa are located in the Mediterranean countries like Portugal, Spain, France and Italy even tough with small samples of patients. In the medical literature, real-world examples of the use of integrase inhibitors in HIV-2 patients are scarce and are limited to some clinical trials [2,3]. Most studies show clear efficacy of raltegravir in these patients, but the examples described with the use of elvitegravir or dolutegravir are still rare, both of which offer the possibility of singletablet regimens [3-6].","PeriodicalId":337186,"journal":{"name":"Madridge Journal of AIDS","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133472596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Psychological Impacts and Treatment of HIV/AIDS among Nigerian Women: New Perspective toward Cultural Implications and Gender Equality","authors":"Abiola Ruth Adimula, I. Ijere","doi":"10.18689/mja-1000109","DOIUrl":"https://doi.org/10.18689/mja-1000109","url":null,"abstract":"","PeriodicalId":337186,"journal":{"name":"Madridge Journal of AIDS","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122195747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Influence of Cognitive Behavioral group Interventions for HIV Seropositive Women living in the face of Childhood Sexual Abuse","authors":"E. Pines","doi":"10.18689/mja-1000108","DOIUrl":"https://doi.org/10.18689/mja-1000108","url":null,"abstract":"Method A quantitative quasi-experimental one-group design was used to test the interventions, which consisted of eight weekly 90-minute group sessions. Baseline data were collected after receiving Institutional Review Board approval. Participants were eleven selfreported HIV positive women survivors with childhood sexual abuse histories. Demographic questions in the questionnaire assessed age, race, ethnicity, and educational level. Two questions measuring engagement in unprotected sex and substance use were asked. Participants completed the 15-question Impact of Event Scale.","PeriodicalId":337186,"journal":{"name":"Madridge Journal of AIDS","volume":"38 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114643106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Priyodarshi Sengupta Niranjan Bhattacharya, A. Bhattacharya, N. Bhattacharya
{"title":"Application of Freshly Collected Amniotic Membrane and Amniotic Fluid in Arthritis and Wound Healing","authors":"Priyodarshi Sengupta Niranjan Bhattacharya, A. Bhattacharya, N. Bhattacharya","doi":"10.18689/mja-1000107","DOIUrl":"https://doi.org/10.18689/mja-1000107","url":null,"abstract":"Bhattacharya N1*, Sengupta P2 and Bhattacharyaa A3 1 Head of the Department of Regenerative Medicine and Translational Science, Dr. Subhas Mukherjee Chair Professor, Director General, Cord Blood Bank, Calcutta School of Tropical Medicine 2Research Associate, Department of Regenerative Medicine and Translational Science, Calcutta School of Tropical Medicine 3Research Associate, Department of Regenerative Medicine and Translational Science, Calcutta School of Tropical Medicine","PeriodicalId":337186,"journal":{"name":"Madridge Journal of AIDS","volume":"122 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116096045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Australian Trans and Gender Diverse (TGD) People and HIV/AIDS: A Discussion Paper","authors":"B. Chaplin, Peta Harbour","doi":"10.18689/mja-1000106","DOIUrl":"https://doi.org/10.18689/mja-1000106","url":null,"abstract":"We are now in the 21st century where Hiv is a treatable chronic condition through the use of antiretroviral therapies (ARTs). Yet, Hiv remains an issue for minority populations who have been disproportionately and adversely affected by Hiv even in first world countries such as Australia. There is no good reason for this. While TGD people may have access to such therapies as ART, the problem is not access to treatment, but recognition that they actually exist. This paper discusses the erasure of TGD people in the Australian healthcare system in the discourse around Hiv, and concludes that their voices need to be heard.","PeriodicalId":337186,"journal":{"name":"Madridge Journal of AIDS","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130678149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}